Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, 120120, China
NCT Number: NCT07186088
To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light
Trial opening soon.
Get Notified18 year–35 year
All sexes
Interventional
Not applicable
Tianjin, Tianjin Municipality, 120120, China
The experiment will be divided into two phases. In the first phase, the subjects will be randomly grouped using laser equipment and LED equipment, and each group will be exposed to the red light twice a day for one month. The second stage involves self-comparison of the laser equipment, with the usage frequencies being once a day and three times a day.
To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light in different devices and frequencies, as well as its impact on the axial length, spherical equivalent refraction and choroidal thickness of myopia progression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eyerising RS-200-2A,1 time,2 times, 3 times a day
Eyerising RS-200-2A,2 times a day
Time frame: From enrollment to the end of treatment up to 7 months
Time frame: From enrollment to the end of treatment up to 7 months
Time frame: From enrollment to the end of treatment up to 7 months
Contact information is provided by the study sponsor or research team.
Ruihua Wei
Other
Study on the Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies for Adult Myopia Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724210
Eye Diseases, Myopia
Beijing, Beijing Municipality, China
View Trial DetailsNCT07406906
Eye Diseases, Myopia
Hong Kong
View Trial DetailsNCT07721714
Astigmatism, Eye Diseases
Palo Alto, California, United States
View Trial DetailsNCT07696468
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial Details